Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230656 · ClinicalTrials.gov registry record · NA

Cognitive-Communication Screening and Early Therapy for Adults With Mild TBI

A NA study of Mild Traumatic Brain Injury and Concussion, sponsored by Northern Arizona University.

Completed
Registry status
NA
Development phase
98
Enrollment target
1
Study location

NCT03230656 is a NA study of Mild Traumatic Brain Injury and Concussion that has completed, run by Northern Arizona University. The registered enrollment target is 98 participants, below the 218-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230656, a NA study of Mild Traumatic Brain Injury and Concussion, has completed, sponsored by Northern Arizona University.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target
1
Study location

Study Summary

Approximately 15-20% of patients diagnosed with a concussion/mild traumatic brain injury (mTBI) have persistent symptoms that continue up to six months or longer. Typical problems identified by these patients include difficulty with memory, multi-tasking, the ability to complete tasks quickly, and higher executive functions (e.g., inhibition, initiation, insight, motivation) (Belanger \& Vanderploeg, 2005; Mott, McConnon, \& Rieger, 2012, Rabinowitz \& Levin, 2014). If these symptoms persist they can not only affect thinking, but also communication abilities (e.g., verbal and nonverbal interactions, reading, and writing) (ASHA, 2007). Therefore, it is hypothesized that screening measures that evaluate both thinking and communication can better identify individuals at-risk for persistent symptoms at two week and four weeks post-injury. Also, if cognitive-communication therapy was administered earlier post-injury, then outcomes related to return to daily activities, work, and/or the academic setting could possibly change. This study intends to investigate the use of cognitive and communication screening measures for the identification of persistent symptoms and the provision of early cognitive-communication therapy if problems persist.

Interventions

  • OTHER Early cognitive-communication therapy

Study Locations (1)

Arizona

  • Northern Arizona University - Flagstaff

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2017-01
Est. Completion 2021-05-31
Phase NA

Sponsor

Northern Arizona University

23 total trials

What the Registry Record Tells You About NCT03230656

The ClinicalTrials.gov registry entry for NCT03230656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (55% lower). The listed sponsor is Northern Arizona University, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Early cognitive-communication therapy is the first listed.

NCT03230656 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03230656 about?

NCT03230656 is a clinical study titled "Cognitive-Communication Screening and Early Therapy for Adults With Mild TBI". Approximately 15-20% of patients diagnosed with a concussion/mild traumatic brain injury (mTBI) have persistent symptoms that continue up to six months or longer. Typical problems identified by these patients include difficulty with memory, multi-tasking, the ability to complete tasks quickly, and h...

What is the current status of trial NCT03230656?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2017-01. Estimated completion is 2021-05-31.

What conditions does trial NCT03230656 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Concussion, Cognitive Communication Disorder.

What interventions are being tested in trial NCT03230656?

The interventions under investigation include: Early cognitive-communication therapy (OTHER).

Who is sponsoring clinical trial NCT03230656?

This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03230656 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.